About Lomustine
            
            Class: | Alkylating agent  
Use: | Treatment of certain types of brain tumors (e.g., gliomas), Hodgkin's lymphoma, and other cancers  
Adult dose: | 130 mg/m² as a single dose every 6 weeks; may vary based on specific condition and patient response  
Pediatric dose: | Not established; use in pediatric patients should be determined by a specialist  
Side effects: | Nausea, vomiting, myelosuppression (bone marrow suppression), hepatotoxicity, pulmonary toxicity, and risk of secondary malignancies 
         
        
            
                
                
                    
                        Drug Class
                    
                    Alkylating agent
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of certain types of brain tumors (e.g., gliomas), Hodgkin's lymphoma, and other cancers
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from moisture and light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Bristol Myers Squibb, CANADA
                    
                    
                    Package Size
                    20s
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1840.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        130 mg/m² as a single dose every 6 weeks; may vary based on specific condition and patient response
                    
                    
                        Pediatric Dose
                    
                    
                        Not established; use in pediatric patients should be determined by a specialist
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, myelosuppression (bone marrow suppression), hepatotoxicity, pulmonary toxicity, and risk of secondary malignancies
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to lomustine or any component of the formulation; severe bone marrow suppression; active infections
         
        
        
            
                Important Warnings
            
            Monitor blood counts regularly due to risk of myelosuppression; may cause fetal harm; use caution in patients with liver or lung disease; potential for secondary malignancies after treatment
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.